Home
Conditions
Vector Borne Diseases

Clinical trial condition

Vector Borne Diseases

Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.

2,038 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Vector Borne Diseases trial results

Completed

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

NCT02628444

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Investigational Site 102 Barranquilla, Colombia

Investigational Site 101 Cali, Colombia

Investigational Site 103 Medellín, Colombia

Investigational Primary Site Muntinlupa 201_Satellite Site San Pablo 202 City of Muntinlupa, Philippines

View Trial Details

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

NCT02824198

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Singapore

Singapore

Singapore

View Trial Details

Completed

Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

NCT01943825

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Syracuse, New York, United States

View Trial Details

Completed

Very Severe Malaria Treated by Intravenous Artesunate

NCT04516317

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +4 more
Locations: Fabrice BRUNEEL Le Chesnay, Île-de-France Region, France

View Trial Details

Completed

Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

NCT04440774

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya, +11 more
Locations: Hospital Universitario "Dr. José Eleuterio González" de la Universidad Autónoma de Nuevo León. Monterrey, Nuevo León, Mexico

View Trial Details

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

NCT00880893

Conditions: Arbovirus Infections, Dengue, Dengue Diseases, +12 more
Locations: Singapore

Singapore

Singapore

Singapore

View Trial Details

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

NCT01374516

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Fortaleza, Ceará, Brazil

Vitória, Espírito Santo, Brazil

Goiânia, Goiás, Brazil

Campo Grande, Mato Grosso do Sul, Brazil

View all 22 locations

View Trial Details

Completed

Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America

NCT01187433

Conditions: Arbovirus Infections, Dengue, Dengue Hemorrhagic Fever, +9 more
Locations: Vitória, Brazil

View Trial Details

Completed

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

NCT01373281

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Denpasar, Bali, Indonesia

Bandung, West Java, Indonesia

Jakarta, Indonesia

Kuala Lumpur, Malaysia

View Trial Details

Completed

ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -

NCT03303898

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +8 more
Locations: Nice Hospital Nice, France

View Trial Details

Vector Borne Diseases

Vector Borne Diseases trial results

Related conditions